ProCE Banner Activity

Myelodysplastic Syndromes: Diagnosis, Classification, and Risk Stratification

Slideset Download

Download these slides from a live symposium for expert insight on the latest changes in classification and prognostic risk stratification for MDS.

Released: December 09, 2022

Expiration: December 08, 2023

No longer available for credit.

Share

Faculty

Rami Komrokji

Rami Komrokji, MD

Professor
Department of Oncologic Sciences
University of South Florida
Vice Chair
Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Bristol Myers Squibb

Geron

Karyopharm Therapeutics Inc.

Novartis Pharmaceuticals Corporation

Program Director Disclosure

Program Director

Rami Komrokji, MD

Professor
Department of Oncologic Sciences
University of South Florida
Vice Chair
Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida

Rami Komrokji, MD: consultant/advisor/speaker: AbbVie, Bristol-Myers Squibb, CTI BioPharma, Geron, Gilead Sciences, Jazz, Novartis, PharmaEssentia, Servier, Taiho, Takeda.